SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-036218
Filing Date
2024-02-14
Accepted
2024-02-14 16:12:56
Documents
2
Group Members
AMIN NATHOOANSON ADVISORS INC.ANSON MANAGEMENT GP LLCMOEZ KASSAMTONY MOORE

Document Format Files

Seq Description Document Type Size
1 SC 13G d764036dsc13g.htm SC 13G 118224
2 EX-99.1 d764036dex991.htm EX-99.1 8271
  Complete submission text file 0001193125-24-036218.txt   128413
Mailing Address 16000 DALLAS PARKWAY SUITE 800 DALLAS TX 75248
Business Address 16000 DALLAS PARKWAY SUITE 800 DALLAS TX 75248 214.866.0202
Anson Funds Management LP (Filed by) CIK: 0001491072 (see all company filings)

IRS No.: 300134498 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Subject) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93211 | Film No.: 24638260
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)